These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 21992534

  • 1. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
    Sasamoto Y, Oshima Y, Miki A, Wakabayashi T, Song D, Matsushita K, Hamasaki T, Nishida K.
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, Otori Y, Kamei M, Kusaka S, Tano Y.
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [Abstract] [Full Text] [Related]

  • 3. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab.
    Zhou M, Chen S, Wang W, Huang W, Cheng B, Ding X, Zhang X.
    Invest Ophthalmol Vis Sci; 2013 Jun 04; 54(6):3874-9. PubMed ID: 23674760
    [Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
    Yazdani S, Hendi K, Pakravan M, Mahdavi M, Yaseri M.
    J Glaucoma; 2009 Jun 04; 18(8):632-7. PubMed ID: 19826393
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
    Eid TM, Radwan A, el-Manawy W, el-Hawary I.
    Can J Ophthalmol; 2009 Aug 04; 44(4):451-6. PubMed ID: 19606170
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
    Duch S, Buchacra O, Milla E, Andreu D, Tellez J.
    J Glaucoma; 2009 Feb 04; 18(2):140-3. PubMed ID: 19225351
    [Abstract] [Full Text] [Related]

  • 9. Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.
    Sugimoto Y, Mochizuki H, Okumichi H, Takumida M, Takamatsu M, Kawamata S, Kiuchi Y.
    Graefes Arch Clin Exp Ophthalmol; 2010 Nov 04; 248(11):1601-9. PubMed ID: 20524132
    [Abstract] [Full Text] [Related]

  • 10. Topical bevacizumab for neovascular glaucoma: a pilot study.
    Waisbourd M, Shemesh G, Kurtz S, Rachmiel R, Moisseiev E, Zayit-Soudri S, Loewenstein A, Barequet I.
    Pharmacology; 2014 Nov 04; 93(3-4):108-12. PubMed ID: 24556733
    [Abstract] [Full Text] [Related]

  • 11. Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma.
    Lim TH, Bae SH, Cho YJ, Lee JH, Kim HK, Sohn YH.
    Korean J Ophthalmol; 2009 Sep 04; 23(3):188-92. PubMed ID: 19794946
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ.
    Br J Ophthalmol; 2009 May 04; 93(5):589-93. PubMed ID: 19074917
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.
    Takihara Y, Inatani M, Kawaji T, Fukushima M, Iwao K, Iwao M, Tanihara H.
    J Glaucoma; 2011 Mar 04; 20(3):196-201. PubMed ID: 20440215
    [Abstract] [Full Text] [Related]

  • 16. Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma.
    Nagendran ST, Finger PT.
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb 04; 46(2):201-7. PubMed ID: 25707045
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in neovascular glaucoma.
    Sevim MS, Buttanri IB, Kugu S, Serin D, Sevim S.
    Ophthalmologica; 2013 Feb 04; 229(2):94-100. PubMed ID: 23364308
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection.
    Ohira S, Inoue T, Shobayashi K, Iwao K, Fukushima M, Tanihara H.
    Invest Ophthalmol Vis Sci; 2015 Jun 04; 56(6):3541-8. PubMed ID: 26030108
    [Abstract] [Full Text] [Related]

  • 20. Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study.
    dell'Omo R, Cassetta M, dell'Omo E, di Salvatore A, Hughes JM, Aceto F, Porcellini A, Costagliola C.
    Am J Ophthalmol; 2012 Jan 04; 153(1):155-61.e2. PubMed ID: 21861975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.